Posts tagged as:

workplace issues

This year’s Health Datapalooza will be held on June 5-6, at the Washington Convention Center in Washington, DC. The event will feature exciting new products, services, applications, and features based on open source health data. Entrepreneurs across the country are submitting their innovations to be judged by panels comprised of health care professionals, community leaders, and consumers. The best inventions will be showcased during the event. It’s an exciting opportunity for entrepreneurs and a great way for pharmacists to stay on top of the next big thing in the healthcare data industry. [click to continue…]

{ 1 comment }

The debate about morning after contraception is unlikely to be resolved soon. Court cases are still pending for pharmacists who object to selling the morning after pill because they believe it to conflict with their religious and/or ethical beliefs. In the mean time, a new morning after pill has been made available in Europe that is said to have a better track record for preventing pregnancy after unprotected sex.

So far only available in Europe and by prescription, the new drug, ellaOne, appears to be longer lasting and more effective than the currently available Plan B birth control. In a recent study of 1700 women half were given Plan B and the other half ellaOne after having unprotected sex. The study found that the instance of pregnancy in the Plan B group was 2.6 percent while the rate in the ellaOne group was 1.8 percent. [click to continue…]

{ 0 comments }

The National Institute for Occupational Safety and Health (NIOSH) is examining evidence to issue recommendations that health care workers that are trying to conceive, pregnant, or breastfeeding be relocated to areas that limit contact with potentially hazardous drugs.  The organization has completed the collection of information and suggestions from industry workers and employers and is currently in the review process.

NIOSH acknowledges that moving employees might be difficult in smaller pharmacy settings but is convinced that the potential for side effects warrants the suggestion.  They cite the increase in negative events such as miscarriage and stillbirths for nurses and pharmacy workers as evidence for the necessity of examination of the guidelines.

They note also that the guides for those “trying to conceive” would also apply to male employees. NIOSH notes that the information collected will likely take around two years to translate in suggested guidelines. There are no plans at this time to draft laws or regulations that employers are required to follow. [click to continue…]

{ 0 comments }

As pharmacist, we are inundated with stress and pressure from our daily work. Often, there isn’t much we can do to eliminate that stress. But two recent court cases, in the US and UK, make it clear that the stakes for dealing with that stress have just gone up considerably.
[click to continue…]

{ 0 comments }

© RPh on the Go, All Rights Reserved.